SANTONI, ADELE
 Distribuzione geografica
Continente #
EU - Europa 360
NA - Nord America 295
AS - Asia 26
AF - Africa 6
OC - Oceania 3
Totale 690
Nazione #
US - Stati Uniti d'America 290
IT - Italia 119
GB - Regno Unito 89
SE - Svezia 48
FR - Francia 32
DE - Germania 21
IE - Irlanda 21
CN - Cina 15
FI - Finlandia 14
EG - Egitto 6
BE - Belgio 5
IN - India 5
IR - Iran 4
AU - Australia 3
CA - Canada 3
UA - Ucraina 3
MX - Messico 2
NL - Olanda 2
AT - Austria 1
CZ - Repubblica Ceca 1
ES - Italia 1
JP - Giappone 1
MK - Macedonia 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
Totale 690
Città #
Southend 81
Chandler 48
Siena 37
Ashburn 35
Fairfield 33
Dublin 21
Florence 20
Princeton 18
Seattle 17
Woodbridge 16
Wilmington 13
Helsinki 12
Shanghai 12
Washington 11
Cambridge 10
Houston 10
Rome 7
Fremont 6
Turin 6
Brussels 5
Fano 4
London 4
San Mateo 4
Ann Arbor 3
Buscate 3
Genova 3
Grosseto 3
Alexandria 2
Beijing 2
Bologna 2
Cairo 2
Chiampo 2
Chiswick 2
Frankfurt am Main 2
Gustavo Adolfo Madero 2
Jacksonville 2
Lappeenranta 2
Lucknow 2
Madinat an Nasr 2
Messina 2
Montecatini Terme 2
Paris 2
Perth 2
Reggio Emilia 2
San Diego 2
Andover 1
Aveiro 1
Bangalore 1
Boardman 1
Bolzano 1
Cerveteri 1
Chennai 1
Falkenstein 1
Groningen 1
Henderson 1
Islamabad 1
Kashan 1
Markham 1
Milan 1
Mumbai 1
Málaga 1
Parma 1
Prad am Stilfser Joch 1
Sacramento 1
San Giovanni Valdarno 1
Shiraz 1
Skopje 1
Sydney 1
Tokyo 1
Toronto 1
Verona 1
Vienna 1
Zanjan 1
Totale 506
Nome #
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 83
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 83
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) 71
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 71
Anti CD38 monoclonal antibodies for multiple myeloma treatment 54
Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of FLT3-ITD in NPM1 mutated AML, irrespectively of FLT3-ITD allelic Burden 53
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 52
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 50
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 39
Circulating CD34+/CD38-/CD26+ Leukemia Stem Cells along Chronic Myeloid Leukemia progression: differences between Chronic, Accelerated and Blast Phase 37
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 32
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 31
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 27
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 21
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 14
Infectious complications after induction chemotherapy with FLAI(E) in newly diagnosed AML, omitting antibacterial prophylaxis 14
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 9
Totale 741
Categoria #
all - tutte 3.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 10 4 4 0 3
2020/2021124 1 4 29 11 11 10 8 16 6 11 2 15
2021/2022167 4 22 14 16 4 5 5 7 8 17 29 36
2022/2023284 12 38 30 27 14 34 12 23 20 4 57 13
2023/2024145 16 14 46 31 38 0 0 0 0 0 0 0
Totale 741